1/3/24 10:41 | 1/2/24 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | S | -18 | 0.9000 | 0 | -20 | 0 | 12,005 | I | | | | | | | | | | | | | | |
12/20/23 10:31 | 12/15/23 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | S | -15 | 0.7500 | 0 | -20 | 0 | 12,025 | I | | | | | | | | | | | | | | |
6/7/22 16:05 | 6/6/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -37 | 2.47 | 0 | -15 | -53 | 13 | D | | | | | | | | | | | | | | |
4/13/22 16:01 | 4/11/22 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -28 | 2.75 | 0 | -10 | -26 | 28 | D | | | | | | | | | | | | | | |
6/2/21 16:36 | 5/28/21 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -35 | 3.54 | 0 | -10 | -29 | 25 | D | | | | | | | | | | | | | | |
2/8/21 16:06 | 2/5/21 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -54 | 5.37 | 0 | -10 | -22 | 35 | D | | | | | | | | | | | | | | |
12/4/20 16:16 | 12/2/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S | -34 | 3.40 | 0 | -10 | -18 | 45 | D | | | | | | | | | | | | | | |
11/19/20 16:21 | 11/17/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S.m | -17 | 3.37 | 0 | -5 | -8 | 55 | D | | | | | | | | | | | | | | |
9/18/20 17:21 | 9/15/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrell Jason Bradley Md | TX | O | Chief Me | S.d | -63 | 3.23 | 0 | -20 | -25 | 60 | D | | | | | | | | | | | | | | |
9/10/20 10:55 | 9/9/20 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | TX | D | | S | -209 | 3.21 | 0 | -65 | -3 | 1,862 | D | | | | | | | | | | | | | | |
9/30/19 16:13 | 9/26/19 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | S | -279 | 6.03 | 0 | -46 | 0 | 11,995 | I | | | | | | | | | | | | | | |
5/24/16 16:57 | 5/20/16 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | U0 | DO | P,CEO | S.d | -12 | 3.54 | 0 | -3 | 0 | 1,137 | M | 93 | -5 | -17 | -1 | -4 | 4 | 5 | 2 | -3 | 4 | -4 | 3 | 28 | |
9/3/14 17:17 | 9/3/14 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | U0 | DOT | CEO,P | S | 0 | 0.00 | 0 | -1,038 | -33 | 2,106 | M | -53 | -1 | -31 | 30 | 13 | 12 | 0 | -3 | 1 | 2 | 110 | 79 | 95 | 72 |
9/3/14 14:21 | 9/3/14 | VNRX | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | U0 | O | Secretar | S | -50 | 1.80 | 0 | -28 | -3 | 1,004 | I | -53 | -1 | -31 | 30 | 13 | 12 | 0 | -3 | 0 | 1 | 109 | 79 | 95 | 72 |